Base Facility
Biomanufacture of synthetic RNA & DNA for academic, translational and commercial research.
![snoopysnap.PNG](https://static.wixstatic.com/media/9e5157_70ec5a1ed6314646bec08615e7cf7bbc~mv2.png/v1/fill/w_588,h_500,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/9e5157_70ec5a1ed6314646bec08615e7cf7bbc~mv2.png)
BASE facility produces high-quality nucleic-acid (mRNA, DNA) to support academic, translational and industrial research. We are interested in the synthesis of RNA/DNA, and its use in mRNA vaccines, synthetic biology and genomics.
BASE hosts accredited and advanced manufacturing facilities and equipment and is staffed by a skilled team of scientists with expertise and experience in nucleic-acid biomanufacture. We work closely with academic, industry and government users to produce synthetic RNA/DNA solutions according to their unique research and translational needs.
BASE is a joint initiative between the National Biologics Facility (NBF) and the Protein Expression Facility (PEF) which enables the provision of high-quality RNA/DNA products. BASE also broadly collaborates with key research groups at AIBN to provide novel solutions for nucleic-acid packaging and delivery.